Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
01/2007
01/24/2007CN1901971A Cyclopropane compounds and pharmaceutical use thereof
01/24/2007CN1900067A Tricyclic compounds, their production and use
01/24/2007CN1296361C Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
01/24/2007CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
01/23/2007US7166724 Ionic liquids
01/23/2007US7166625 Method for treating fibrotic diseases and other indications
01/23/2007US7166620 control of phytopathogenic fungi; e.g (E)-3-methoxy-2-{2-[2-(trifluoromethyl)-5-methylthiazol-4-yloxymethyl]-phenyl}acrylate
01/23/2007US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus
01/23/2007US7166593 Glucocorticoid receptor modulators
01/23/2007US7166590 Antiischemic agents; cardiovascular disorders
01/18/2007WO2007009083A2 Compounds with activity at retinoic acid receptors
01/18/2007WO2007007886A1 An oxime derivative and preparations thereof
01/18/2007WO2007007018A1 Piperazine heteroaryl derivates as gpr38 agonists
01/18/2007WO2007006814A1 Urea glucokinase activators
01/18/2007WO2007006760A1 Dicycloalkyl urea glucokinase activators
01/18/2007US20070015918 Derivatives of 1,3-diones having a herbicidal activity
01/18/2007US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
01/18/2007US20070015762 NPY Y5 antagonist
01/18/2007US20070015755 Novel compounds and compositions as protease inhibitors
01/18/2007CA2615938A1 Urea glucokinase activators
01/18/2007CA2614930A1 Glutamate aggrecanase inhibitors
01/18/2007CA2614518A1 Dicycloalkyl urea glucokinase activators
01/18/2007CA2613458A1 Compounds with activity at retinoic acid receptors
01/17/2007EP1743333A1 Metal chelates and their use in optical recording media having high storage capacity
01/17/2007EP1742942A1 Phenylthioacetic acid derivatives and use thereof
01/17/2007EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
01/17/2007EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof
01/17/2007EP1742907A2 Certain chemical entities, compositions, and methods
01/17/2007EP1742903A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
01/17/2007EP1742902A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
01/17/2007EP1383751B1 Novel azoles having an insecticidal action
01/17/2007CN1898221A Modulators of atp-binding cassette transporters
01/17/2007CN1898220A Method of obtaining 2-mercaptobenzothiazole
01/17/2007CN1898218A 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes
01/17/2007CN1898213A Heteroaroyl-substituted phenylalanineamides with herbicidal action
01/17/2007CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
01/17/2007CN1896069A Substituted-thiazole-4-ketone, its preparation and use
01/17/2007CN1895047A Agents for combatting plant pests
01/17/2007CN1295222C Improved method for preparing thiazolidine-2,4-dione derivative
01/16/2007US7164027 Aralkyl ester soft drugs
01/16/2007US7163952 Azole compound and medicinal use thereof
01/16/2007CA2253453C Alkylaminobenzothiazole and -benzoxazole derivatives
01/11/2007WO2007005785A1 Thiazoles derivatives as ampk activator
01/11/2007WO2007003944A2 Compounds for imaging and therapy
01/11/2007WO2007003767A2 Novel chemical compounds and the uses thereof as a medicine
01/11/2007WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor
01/11/2007WO2006117669B1 Amide resorcinol compounds
01/11/2007US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/11/2007US20070010563 Novel methods for the treatment of inflammatory diseases
01/11/2007US20070010562 Nr1h4 nuclear receptor binding compounds
01/11/2007US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
01/11/2007US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/11/2007US20070010528 excellent efficacy, oral absorbability, sustained effect, fewer side effects; for thrombosis; anticoagulants; N-(4-((4-( 3-((6-chloro-2-naphthyl)sulfonyl)propanoyl)-1-piperazinyl)methyl)-3-methyl-1,3-thiazol-2(3H)-ylidene)-N-methylamine
01/11/2007DE102005025989A1 Carboxamide Carboxamides
01/11/2007CA2614098A1 Thiazoles derivatives as ampk activator
01/11/2007CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor
01/10/2007EP1741709A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/10/2007EP1740560A1 Tri(cyclo) substituted amide compounds
01/10/2007EP1740541A2 Therapeutic formulations of desoxyepothilones
01/10/2007EP1740531A1 Indene derivatives and process for the preparation thereof
01/10/2007EP1453505A4 Use of pramipexole to treat amyotrophic lateral sclerosis
01/10/2007EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives
01/10/2007CN1894344A Compounds for dual photodiagnosis and therapy
01/10/2007CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
01/10/2007CN1891697A Agents for combatting plant pests
01/10/2007CN1891689A Aliphatic nitrogen - containing 5 - membered ring compound
01/10/2007CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof
01/10/2007CN1294121C Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage
01/10/2007CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
01/09/2007US7161011 Reactin a thiazole compound with glycidyl aldehyde
01/09/2007US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease
01/09/2007US7160903 Sulfonylaminocarboxylic acids
01/09/2007US7160887 Aromatic amine derivatives, their production and use
01/09/2007CA2394720C Cyanomethylene compounds and fungicidal compositions
01/09/2007CA2380169C A process for preparing 4-cyano-2-aminomethylthiazole
01/09/2007CA2380084C A process for preparing 2-aminomethyl-4-cyano-thiazole
01/09/2007CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
01/04/2007WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/04/2007WO2007002461A1 3,4-substituted thiazoles as ampk activators
01/04/2007WO2007002172A2 Hiv-1 protease inhibitors
01/04/2007WO2007002126A1 Alkyl sulfonamide derivatives
01/04/2007WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases
01/04/2007WO2007000246A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/04/2007WO2005012297A9 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
01/04/2007US20070004921 Isopentyl carboxanilides for combating undesired micro-organisms
01/04/2007US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
01/04/2007US20070004751 Substituted heterocyclic compounds
01/04/2007US20070004718 Ion channel modulating compounds and uses thereof
01/04/2007US20070004704 Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X
01/04/2007CA2667445A1 Hiv-1 protease inhibitors
01/04/2007CA2613377A1 Alkyl sulfonamide derivatives
01/04/2007CA2611953A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/04/2007CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/03/2007EP1739083A1 Benzylidene-1,3-thiazolidine-2,4-dione compounds, uses thereof and compositions for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibres
01/03/2007EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
01/03/2007EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
01/03/2007EP1737818A2 Methods for the preparation of stereoisomerically enriched amines
01/03/2007EP1737809A2 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
01/03/2007EP1737450A1 Aqueous composition comprising thiazole derivative
01/03/2007EP1737414A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain